相关实验视频
Updated: Jun 28, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
在临床实践中对帕金森病进行深度大脑刺激的基础:第二部分
Mariana Moscovich1, Camila Henriques de Aquino2,3,4, Murilo Martinez Marinho4
1Christian-Albrechts University, Department of Neurology, Kiel, Germany.
Arquivos de neuro-psiquiatria
|April 23, 2024
概括
神经调节疗法正在以新的目标和技术进步. 本综述涵盖了用于治疗干预的电极放置,机制和聚焦超声波.
科学领域:
- 神经调节是一种神经调节.
- 神经外科 神经外科
- 生物医学工程 生物医学工程
背景情况:
- 神经调节领域在过去十年中取得了重大进展.
- 硬件,软件和刺激技术的创新扩大了其治疗应用.
- 本综述是记录基本和最近发展的努力的第二部分.
研究的目的:
- 审查神经调节中的经典和新型电极放置范式.
- 探索神经调节技术背后的机制.
- 讨论新进展,包括聚焦超声波除性手术.
主要方法:
- 文献综述专注于神经调节技术和应用.
- 分析了经典的电极放置策略.
- 检查新兴的神经调节技术和机制.
- 包括聚焦超声波作为一个废除程序.
主要成果:
- 神经调节提供了强大的治疗干预措施,范围不断扩大.
- 新的目标和创新的技术正在不断发展.
- 聚焦超声波代表了废除神经调节程序的新前沿.
结论:
- 神经调节是一个快速发展的领域,具有显著的治疗潜力.
- 对机制和目标的持续研究将推动进一步的创新.
- 像聚焦超声波这样的先进技术为治疗提供了新的可能性.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
10.9K
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537